Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC
Clinical trial NCT04211090 · UNKNOWN
Trial details
- NCT number
- NCT04211090
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2022-08-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.